Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9 USD | +4.53% | +1.81% | -16.08% |
09/05 | Transcript : Oncternal Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Oncternal Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.08% | 26.64M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+45.55% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+25.72% | 12.26B | |
+27.17% | 12.05B |
- Stock Market
- Equities
- ONCT Stock
- News Oncternal Therapeutics, Inc.
- Oncternal Therapeutics Says US FDA Clears Study of New Drug for Treatment of Aggressive B Cell Lymphoma; Shares Rise